 | Mark D. Bracker - 2001 - 662 páginas
...Rheumatoid arthritis: the clinical features. J Musculoskel Med 1993; 10:85-95. Smolen J, Kalden J, Scott D, et al. Efficacy and safety of leflunomide compared...and sulphasalazine in active rheumatoid arthritis: a double blind, randomized, muticentre trial. Lancet 1999; 353:259-266. Author: Nick Carter REHABILITATION... | |
 | Sterling G. West - 2002 - 718 páginas
...or penicillamine: A comparison using life-table methods. Ann Rheum Dis 46:177, 1987. 12. Smolen J. et al: Efficacy and safety of leflunomide compared...double-blind, randomized, multicentre trial. Lancet 353:259-266, 1999. 13. Van Beek MJ, Piette WW: Antimalarials. Dermatol Clin 19:147-160, 2001. MONTHLY... | |
 | Richard S. Weiner - 2001 - 1172 páginas
...Larsen, A., Loew-Friedrich, I., Oed, C., Rosenburg, R., & The European Leflunomid Study Group. (1999). Efficacy and safety of leflunomide compared with placebo...sulphasalazine in active rheumatoid arthritis; a double-blind, randomised, multicentre trial. Lancet, 353, 259-266. Smythe, HA (1989). Nonarticular rheumatism and... | |
 | Rainer W.G. Gruessner, David E.R. Sutherland - 2004 - 736 páginas
...altered lymphocyte trafficking for the mechanism of action of FTY720. Am J Transplant 2001; 1:474. 268. Smolen JS, Kalden JR. Scott DL, et al. Efficacy and...rheumatoid arthritis: A double-blind, randomized, multicenter trial. European Leflunomide Study Group. Lancet 1999; 253:259-266. 269. Bartlett RR, Dimitrijevic... | |
 | E. William St. Clair, David S. Pisetsky, Barton F. Haynes - 2004 - 580 páginas
...treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials. / Rlieumatol 1999^6:21232130. Smolen JS, Kalden JR, Scott DL, et al. Efficacy and...Sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 1999;353:259-266. Faarvang... | |
 | Herbert H. Zaretsky, Edwin F. Richter, Myron G. Eisenberg - 2005 - 945 páginas
...Osteoarthritis. Maryland Medical Journal, 33, 712-716. Smolen, JS, Kalden, JR, & Scott, DL (1999). Efficacy and safety of leflunomide compared with placebo...arthritis: A double-blind, randomized, multicentre trial. European Leflunomide Study Group. Lancet, 353, 259-266. Solomon, G. (1991). Inflammatory arthritis.... | |
 | Richard O. Day, Daniel E. Furst, Piet L.C.M. van Riel, Barry Bresnihan - 2010 - 350 páginas
...B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenberg R (1999) European Leflunomide Study Group. Efficacy and safety of leflunomide compared with placebo...and sulphasalazine in active rheumatoid arthritis: a double blind, randomised, multicentre trial. Lancet 353: 259-266 46 Haagsma CJ, van Riel PLCM, de Jong... | |
 | Michael Hamacher, Katrin Marcus, Kai Stühler, Andre van Hall, Bettina Warscheid, Helmut E. Meyer - 2006 - 392 páginas
...R., SCOTT, DL, ROZMAN, B., KVIEN, TK, LARSEN, A., LOEW-FRIEDRICH, I., OED, C., ROSENBURG, R. (1999). Efficacy and safety of Leflunomide compared with placebo...sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multi-centre trial. Lancet 353, 259-266. STRAND, V., COHEN, S., SCHIFF, M., WEAVER, A.,... | |
 | Josef S. Smolen, Peter E. Lipsky - 2007 - 636 páginas
...Measures. Reduced joint count in rheumatoid arthritis clinical trials. Arthritis Rheum 1994; 37: 463^. 42. Smolen JS, Kalden JR, Scott DL et al. Efficacy and...sulphasalazine in active rheumatoid arthritis: a doubleblind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 1999; 353(9149): 259-66. 43.... | |
 | John H. Klippel, John H. Stone, L eslie J. Crofford, Patience H. White - 2008 - 721 páginas
...arthritis with luflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159: 2542-2550. 8. Smolen JS, Kalden JR, Scott DL, et al. Efficacy and...sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 1999;353:259-266. 9. Fox RI. Mechanism of action of hydroxychloroquine... | |
| |
Smolen JS, Kalden JR. Scott DL, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. 